α and 1–β [Power / Sample Size]

posted by Helmut Homepage – Vienna, Austria, 2017-12-27 13:31  – Posting: # 18102
Views: 23,887

Hi Yura,

» » If the protocol was approved by the IEC and the competent regulatory agency
»
» yes, explanations are needed for estimating the sample size and design (that to reduce it)

Sure. But once explanations (better: assumptions) were accepted (i.e., the protocol approved) that’s the end of the story. That’s why I’m extremely wary of using the term “forced bioequivalence” in a regulatory context (see also this post and followings).
IMHO, post hoc power is crap. The chance to get one which is higher than planned is ~50%. Run my simulation code and at the end:

cat(nsims, "simulated studies with \u201Cpost hoc\u201D power of",
    "\n  \u2265 target    :", sprintf("%5.2f%%",
    100*length(res[, 3][res[, 3] >= target])/nsims),
    "\n  \u2265 achieved  :", sprintf("%5.2f%%",
    100*length(res[, 3][res[, 3] >= plan[["Achieved power"]]])/nsims),
    "\n  \u2265 0.90      :", sprintf("%5.2f%%",
    100*length(res[, 3][res[, 3] >= 0.9])/nsims),
    "\n  [0.95, 0.99]:", sprintf("%5.2f%%",
    100*length(res[, 3][res[, 3] >= 0.95 & res[, 3] <=0.99])/nsims),
    "\n  \u2265 0.95      :", sprintf("%5.2f%%",
    100*length(res[, 3][res[, 3] >= 0.95])/nsims), "\n")


With your example (CV 0.25, GMR 0.95, target power 80%, n 28, 105 simulations):

1e+05 simulated studies with “post hoc” power of
  ≥ target    : 49.92%
  ≥ achieved  : 48.02%
  ≥ 0.90      : 22.93%
  [0.95, 0.99]:  8.40%
  ≥ 0.95      :  9.70%

Although the study was performed with 28 subjects for ~81% power, the chance to get a post hoc power of ≥ 90% is ~23% and ≥ 95% is ~10%. That’s clearly not “forced BE” and none of these studies should be questioned by regulators.*
I suggest to reserve this term to the context of study planning.



Cheers,
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

Activity
 Admin contact
20,258 posts in 4,264 threads, 1,397 registered users;
online 15 (1 registered, 14 guests [including 10 identified bots]).
Forum time (Europe/Vienna): 20:53 UTC

You should treat as many patients as possible with the new drugs
while they still have the power to heal.    Armand Trousseau

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5